News Focus
News Focus
Post# of 257484
Next 10
Followers 843
Posts 122926
Boards Moderated 9
Alias Born 09/05/2002

Re: JohnWayne post# 216632

Wednesday, 07/11/2018 11:26:23 AM

Wednesday, July 11, 2018 11:26:23 AM

Post# of 257484
MRK—PDUFA for Keytruda-monotherapy sBLA in second-line HCC is 11/9/18 (with priority review):

https://www.businesswire.com/news/home/20180711005195/en/FDA-Grants-Priority-Review-Merck%E2%80%99s-Supplemental-Biologics

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today